The prevalence of child and adolescent obesity has plateaued at high levels in most high-
income countries and is increasing in many low-income and middle-income countries …

Maturity-onset diabetes of the young (MODY) is characterized by autosomal dominant
inheritance, onset before 25 years of age, absence of β-cell autoimmunity, and sustained …

You have in your hands, or at your fingertips, the first edition of the American Academy of
Pediatrics clinical practice guideline for evaluation and management of children and …

Aims We aimed to conduct a systematic review of published studies on the incidence of type
2 diabetes in children and adolescents aged under 20 years and provide worldwide …

Although all types of diabetes result in hyperglycemia, the pathophysiology of each type of
diabetes is different. These guidelines summarize available data specific to the …

Background Metformin is the regulatory-approved treatment of choice for most youth with
type 2 diabetes early in the disease. However, early loss of glycemic control has been …

Type 2 diabetes diagnosed in childhood or early adulthood is termed early-onset type 2
diabetes. Cases of early-onset type 2 diabetes are increasing rapidly globally, alongside …

Importance The childhood obesity epidemic is presumed to drive pediatric type 2 diabetes
(T2D); however, the global scale of obesity in children with T2D is unknown. Objectives To …

The incidence and prevalence of youth-onset type 2 diabetes mellitus (T2DM) and its
complications are increasing worldwide. Youth-onset T2DM has been reported in all racial …

Background Since there are few treatment options for young people with type 2 diabetes, we
aimed to assess the efficacy and safety of dapagliflozin as add-on therapy in children …